Contemporary pacemakers: What the primary care physician needs to know

Mayo Clinic Proceedings

Volumn 83, Issue 10, 2008, Pages 1170-1186

  Kaszala, Karoly ^a   Huizar, Jose F ^a   Ellenbogen, Kenneth A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOGENIC SHOCK; COMORBIDITY; CONFERENCE PAPER; DEFIBRILLATOR; FUNCTIONAL ASSESSMENT; HEART BLOCK; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART PACING; HUMAN; PACEMAKER ELECTRODE; PHYSICIAN; PRIMARY MEDICAL CARE; SINUS NODE DISEASE; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT INDICATION; CLINICAL COMPETENCE; EQUIPMENT DESIGN; GENERAL PRACTITIONER; METHODOLOGY; REVIEW;

BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; CLINICAL COMPETENCE; EQUIPMENT DESIGN; HUMANS; PACEMAKER, ARTIFICIAL; PHYSICIANS, FAMILY;

EID: 54049110387     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.10.1170     Document Type: Conference Paper

References (81)

1. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol. 2002;40(9):1703-1719.
2. Chandler D, Rosenbaum J. Severe Adams-Stokes syndrome treated with isuprel and an artificial pacemaker. Am Heart J. 1955;49(2):295-301.
3. Bernstein AD, Parsonnet V. Survey of cardiac pacing and defibrillation in the United States in 1993. Am J Cardiol. 1996;78(2):187-196.
4. Bernstein AD, Daubert JC, Fletcher RD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. Pacing Clin Electrophysiol. 2002;25(2):260-264.
5. Lau CP, Butrous GS, Ward DE, Camm AJ. Comparison of exercise performance of six rate-adaptive right ventricular cardiac pacemakers. Am J Cardiol. 1989;63(12):833-838.
6. Baig MW, Boute W, Begemann M, Perrins EJ. One-year follow-up of automatic adaptation of the rate response algorithm of the QT sensing, rate adaptive pacemaker. Pacing Clin Electrophysiol. 1991;14(11, pt 1):1598-1605.
7. Landman MA, Senden PJ, van Rooijen H, van Hemel NM. Initial clinical experience with rate adaptive cardiac pacing using two sensors simultaneously. Pacing Clin Electrophysiol. 1990;13(12, pt 1):1615-1622.
8. Mond H, Strathmore N, Kertes P, Hunt D, Baker G. Rate responsive pacing using a minute ventilation sensor. Pacing Clin Electrophysiol. 1988;11(11, pt 2):1866-1874.
9. Ovsyshcher I, Guldal M, Karaoguz R, Katz A, Bondy C. Evaluation of a new rate adaptive ventricular pacemaker controlled by double sensors. Pacing Clin Electrophysiol. 1995;18(3, pt 1):386-390.
10. Lewalter T, MacCarter D, Jung W, et al. The "low intensity treadmill exercise" protocol for appropriate rate adaptive programming of minute ventilation controlled pacemakers. Pacing Clin Electrophysiol. 1995;18(7):1374-1387.
11. Lamas GA, Lee KL, Sweeney MO, et al; Mode Selection Trial in Sinus-Node Dysfunction. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002;346(24):1854-1862.
12. Lamas GA, Orav EJ, Stambler BS, et al; Pacemaker Selection in the Elderly Investigators. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med. 1998;338(16):1097-1104.
13. Ellenbogen KA, Kapadia K, Walsh M, Mohanty PK. Increase in plasma atrial natriuretic factor during ventriculoatrial pacing. Am J Cardiol. 1989;64(3):236-237.
14. Ellenbogen KA, Thames MD, Mohanty PK. New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventriculo-atrial pacing. Am J Cardiol. 1990;65(1):53-59.
15. Gallik DM, Guidry GW, Mahmarian JJ, Verani MS, Spencer WH III. Comparison of ventricular function in atrial rate adaptive versus dual chamber rate adaptive pacing during exercise. Pacing Clin Electrophysiol. 1994;17(2):179-185.
16. Reiter MJ, Hindman MC. Hemodynamic effects of acute atrioventricular sequential pacing in patients with left ventricular dysfunction. Am J Cardiol. 1982;49(4):687-692.
17. Rosenqvist M, Isaaz K, Botvinick EH, et al. Relative importance of activation sequence compared to atrioventricular synchrony in left ventricular function. Am J Cardiol. 1991;67(2):148-156.
18. Sulke N, Dritsas A, Bostock J, Wells A, Morris R, Sowton E. "Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices. Br Heart J. 1992;67(1):57-64.
19. Grimm W, Langenfeld H, Maisch B, Kochsiek K. Symptoms, cardiovascular risk profile and spontaneous ECG in paced patients: a five-year follow-up study. Pacing Clin Electrophysiol. 1990;13(12, pt 2):2086-2090.
20. Hesselson AB, Parsonnet V, Bernstein AD, Bonavita GJ. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing. J Am Coll Cardiol. 1992;19(7):1542-1549.
21. Rosenqvist M, Brandt J, Schuller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J. 1988;116(1, pt 1):16-22.
22. Zanini R, Facchinetti AI, Gallo G, Cazzamalli L, Bonandi L, Dei Cas L. Morbidity and mortality of patients with sinus node disease: comparative effects of atrial and ventricular pacing. Pacing Clin Electrophysiol. 1990;13(12, pt 2):2076-2079.
23. Adomian GE, Beazell J. Myofibrillar disarray produced in normal hearts by chronic electrical pacing. Am Heart J. 1986;112(1):79-83.
24. Lee MA, Dae MW, Langberg JJ, et al. Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology. J Am Coll Cardiol. 1994;24(1):225-232.
25. van Oosterhout MF, Prinzen FW, Arts T, et al. Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation. 1998;98(6):588-595.
26. Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997;350(9086):1210-1216.
27. Rosenqvist M, Brandt J, Schuller H. Atrial versus ventricular pacing in sinus node disease: a treatment comparison study. Am Heart J. 1986;111(2):292-297.
28. Santini M, Alexidou G, Ansalone G, Cacciatore G, Cini R, Turitto G. Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. Am J Cardiol. 1990;65(11):729-735.
29. Sweeney MO, Hellkamp AS, Ellenbogen KA, et al; MOde Selection Trial Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003 Jun 17;107(23):2932-2937. Epub 2003 Jun 2.
30. Thambo JB, Bordachar P, Garrigue S, et al. Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation. 2004 Dec 21;110(25):3766-3772. Epub 2004 Dec 6.
31. DAVID Trial Investigators. Dual-chamber pacing or ventricular back-up pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288(24):3115-3123.
32. Gammage MD, Marsh AM. Randomized trials for selective site pacing: do we know where we are going? Pacing Clin Electrophysiol. 2004;27(6, pt 2):878-882.
33. Sweeney MO, Bank AJ, Nsah E, et al; Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med. 2007;357(10):1000-1008.
34. Baldasseroni S, Opasich C, Gorini M, et al; Italian Network on Congestive Heart Failure Investigators. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian Network on Congestive Heart Failure. Am Heart J. 2002;143(3):398-405.
35. Shamim W, Francis DP, Yousufuddin M, et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol. 1999;70(2):171-178.
36. Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol. 1999;33(6):1735-1742.
37. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure [published correction appears in J Am Coll Cardiol. 2003;41(10):1852]. J Am Coll Cardiol. 2003;41(5):765-770.
38. Xiao HB, Lee CH, Gibson DG. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br Heart J. 1991;66(6):443-447.
39. Shaw DB, Holman RR, Gowers JI. Survival in sinoatrial disorder (sick-sinus syndrome). Br Med J. 1980;280(6208):139-141.
40. Alboni P, Menozzi C, Brignole M, et al. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome: the THEOPACE study: a randomized controlled trial. Circulation. 1997;96(1):260-266.
41. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet. 1994;344(8936):1523-1528.
42. Connolly SJ, Kerr CR, Gent M, et al; Canadian Trial of Physiologic Pacing Investigators. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med. 2000;342(19):1385-1391.
43. Dretzke J, Toff WD, Lip GY, Raftery J, Fry-Smith A, Taylor R. Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block. Cochrane Database Syst Rev. 2004(2):CD003710.
44. Toff WD, Camm AJ, Skehan JD; United Kingdom Pacing and Cardiovascular Events (UKPACE) Trial Investigators. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med. 2005;353(2):145-155.
45. Healey JS, Toff WD, Lamas GA, et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation. 2006 Jul 4;114(1):11-17. Epub 2006 Jun 26.
46. Castelnuovo E, Stein K, Pitt M, Garside R, Payne E. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. Health Technol Assess. 2005;9(49):1-246.
47. Benditt DG, Petersen M, Lurie KG, Grubb BP, Sutton R. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med. 1995;122(3):204-209.
48. Petersen ME, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J. 1994;71(3):274-281.
49. Sheldon R, Koshman ML, Wilson W, Kieser T, Rose S. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol. 1998;81(2):158-162.
50. Sutton R, Brignole M, Menozzi C, et al; Vasovagal Syncope International Study (VASIS) Investigators. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. Circulation. 2000;102(3):294-299.
51. Ammirati F, Colivicchi F, Santini M; Syncope Diagnosis and Treatment Study Investigators. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation. 2001;104(1):52-57.
52. Connolly SJ, Sheldon R, Roberts RS, Gent M; Vasovagal Pacemaker Study Investigators. The North American Vasovagal Pacemaker Study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 1999;33(1):16-20.
53. Connolly SJ, Sheldon R, Thorpe KE, et al; VPS II Investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA. 2003;289(17):2224-2229.
54. Brignole M, Menozzi C, Lolli G, Bottoni N, Gaggioli G. Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome. Am J Cardiol. 1992;69(12):1039-1043.
55. Kenny RA, Richardson DA, Steen N, Bexton RS, Shaw FE, Bond J. Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). J Am Coll Cardiol. 2001;38(5):1491-1496.
56. Hochleitner M, Hörtnagl H, Ng CK, Hortnagl H, Gschnitzer F, Zechmann W. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol. 1990;66(2):198-202.
57. Brecker SJ, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy [published correction appears in Lancet. 1992;340(8833):1482]. Lancet. 1992;340(8831):1308-1312.
58. Gold MR, Feliciano Z, Gottlieb SS, Fisher ML. Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol. 1995;26(4):967-973.
59. Nishimura RA, Hayes DL, Holmes DR Jr, Tajik AJ. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study. J Am Coll Cardiol. 1995;25(2):281-288.
60. Farwell D, Patel NR, Hall A, Ralph S, Sulke AN. How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J. 2000;21(15):1246-1250.
61. Cazeau S, Leclercq C, Lavergne T, et al; Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344(12):873-880.
62. Kass DA, Chen CH, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation. 1999;99(12):1567-1573.
63. Butter C, Auricchio A, Stellbrink C, et al; Pacing Therapy for Chronic Heart Failure II Study Group. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation. 2001;104(25):3026-3029.
64. Bristow MR, Saxon LA, Boehmer J, et al; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140-2150.
65. Cleland JG, Daubert JC, Erdmann E, et al; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005 Apr 14;352(15):1539-1549. Epub 2005 Mar 7.
66. Gras D, Mabo P, Tang T, et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol. 1998;21(11, pt 2):2249-2255.
67. Kuhlkamp V; InSync 7272 ICD World Wide Investigators. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol. 2002;39(5):790-797.
68. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40(1):111-118.
69. Stellbrink C, Breithardt OA, Franke A, et al; PATH-CHF (PAcing THerapies in Congestive Heart Failure) Investigators; CPI Guidant Congestive Heart Failure Research Group. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol. 2001;38(7):1957-1965.
70. Abraham WT, Fisher WG, Smith AL, et al; MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346(24):1845-1853.
71. Young JB, Abraham WT, Smith AL, et al; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289(20):2685- 2694.
72. Summary of Safety and Effectiveness Original PMA P010012 CONTAK CD CRT-D System and EASYTRAK Coronary Venous Steroid-Eluting Single-Electrode Pace/Sense Lead, Models 4510, 4511, 4512, 4513. US Food and Drug Administration Web site. www.fda.gov/cdrh/pdf/P010012b.pdf. Accessed August 19, 2008.
73. McAlister FA, Ezekowitz J, Hooton N, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007;297(22):2502-2514.
74. Baranowski B, Civello KC Jr, Wilkoff BL, Starling R, Grimm RA. Lack of echocardiographic evidence of dyssynchrony predicts poor relative survival following cardiac resynchronization therapy [abstract AB33-4]. Heart Rhythm. 2006;3(5)(suppl 1):S69.
75. Gorcsan J III, Tanabe M, Bleeker GB, et al. Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy. J Am Coll Cardiol. 2007 Oct 9;50(15):1476-1483. Epub 2007 Sep 24.
76. Bleeker GB, Kaandorp TA, Lamb HJ, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006 Feb 21;113(7):969-976. Epub 2006 Feb 13.
77. Gasparini M, Mantica M, Galimberti P, et al. Is the left ventricular lateral wall the best lead implantation site for cardiac resynchronization therapy? Pacing Clin Electrophysiol. 2003;26(1, pt 2):162-168.
78. Heist EK, Fan D, Mela T, et al. Radiographic left ventricular-right ventricular interlead distance predicts the acute hemodynamic response to cardiac resynchronization therapy. Am J Cardiol. 2005;96(5):685-690.
79. Jansen AH, Bracke FA, van Dantzig JM, et al. Correlation of echo-Doppler optimization of atrioventricular delay in cardiac resynchronization therapy with invasive hemodynamics in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2006 Feb 15;97(4):552-557. Epub 2006 Jan 4.
80. Porciani MC, Dondina C, Macioce R, et al. Echocardiographic examination of atrioventricular and interventricular delay optimization in cardiac resynchronization therapy. Am J Cardiol. 2005;95(9):1108-1110.
81. Beshai JF, Grimm RA, Nagueh SF, et al; RethinQ Study Investigators. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007 Dec 13;357(24):2461-2471. Epub 2007 Nov 6.